An interventional study of IPL/Lipiflow and IPL/MGX in Meibomian Gland Dysfunction, sponsored by Aier School of Ophthalmology, Central South University. Status unknown. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2020-11-18.
Sponsored by Aier School of Ophthalmology, Central South University · Not applicable, Interventional, and Treatment
To compare the effect of IPL combined with lipiflow and IPL combined with meibomian gland massage in treating meibomian gland dysfunction of different degrees ,focusing on effective rate, lasting time and changes of meibomian gland function and morphology.
To divide all participants into two groups, group one treated with IPL combined with Lipiflow and group two treated with IPL combined with meibomian gland massage.The following parameters were recorded after treatment: the effective rate, lasting time and changes of meibomian gland function and morphology.All parameters were compared between the two groups.
Exclusion Criteria:
the group in which patients treated with IPL combined with lipiflow
Procedure: IPL/Lipiflow
the group in which patients treated with IPL combined with meibomian gland massage
Procedure: IPL/MGX
To treat patients with MGD using intense pulsed light combined with lipiflow
To treat patients with MGD using intense pulsed light combined with meibomian gland massage
ocular surface disease index(OSDI)
The OSDI is assessed on a scale of 0 to 100,with higher scores representing greater disability
Time frame: 6 months
meibomian gland expressibility score and meibum quality score
The score is on a scale of 0 to 6.The higher scores, the severity of the meibomian gland function(the highest score is 6 and the lowest score is 0)
Time frame: 6 months
meibomian gland dropout score
the higher scores, the severity of the meibomian gland morphology(The highest score is 6 and the lowest score is 0)
Time frame: 6 months
Breakup time
the shorter time, the poorer of the tear film stability
Time frame: 6 months
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Aier School of Ophthalmology, Central South University